CN101104862B - Synthesis of D-arylglycine by heterogeneous enzyme-catalyzed hydrolysis of 5-arylhydantoin - Google Patents
Synthesis of D-arylglycine by heterogeneous enzyme-catalyzed hydrolysis of 5-arylhydantoin Download PDFInfo
- Publication number
- CN101104862B CN101104862B CN200710062118A CN200710062118A CN101104862B CN 101104862 B CN101104862 B CN 101104862B CN 200710062118 A CN200710062118 A CN 200710062118A CN 200710062118 A CN200710062118 A CN 200710062118A CN 101104862 B CN101104862 B CN 101104862B
- Authority
- CN
- China
- Prior art keywords
- reaction
- arylglycine
- enzyme
- add
- arylhydantoin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000007062 hydrolysis Effects 0.000 title claims abstract description 18
- 238000006460 hydrolysis reaction Methods 0.000 title claims abstract description 18
- 238000003786 synthesis reaction Methods 0.000 title abstract description 6
- 230000015572 biosynthetic process Effects 0.000 title abstract description 5
- 238000006243 chemical reaction Methods 0.000 claims abstract description 76
- 108090000790 Enzymes Proteins 0.000 claims abstract description 52
- 102000004190 Enzymes Human genes 0.000 claims abstract description 52
- 238000002360 preparation method Methods 0.000 claims abstract description 36
- 238000000034 method Methods 0.000 claims abstract description 33
- 239000000758 substrate Substances 0.000 claims abstract description 27
- 238000006555 catalytic reaction Methods 0.000 claims abstract description 18
- 239000013078 crystal Substances 0.000 claims description 26
- 230000000694 effects Effects 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 12
- 238000004811 liquid chromatography Methods 0.000 claims description 10
- 229940091173 hydantoin Drugs 0.000 claims description 9
- 238000000926 separation method Methods 0.000 claims description 8
- 102100036238 Dihydropyrimidinase Human genes 0.000 claims description 5
- 108091022884 dihydropyrimidinase Proteins 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- AHRDDAGNPCRNSH-UHFFFAOYSA-N 5-naphthalen-1-ylimidazolidine-2,4-dione Chemical compound O=C1NC(=O)NC1C1=CC=CC2=CC=CC=C12 AHRDDAGNPCRNSH-UHFFFAOYSA-N 0.000 claims description 4
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 claims description 4
- 238000010189 synthetic method Methods 0.000 claims 1
- 230000008569 process Effects 0.000 abstract description 21
- 241000894006 Bacteria Species 0.000 abstract description 10
- 239000007787 solid Substances 0.000 abstract description 10
- 241000589155 Agrobacterium tumefaciens Species 0.000 abstract description 4
- 239000003054 catalyst Substances 0.000 abstract description 3
- 238000005265 energy consumption Methods 0.000 abstract description 3
- 238000001704 evaporation Methods 0.000 abstract description 3
- 230000008020 evaporation Effects 0.000 abstract description 3
- 238000000855 fermentation Methods 0.000 abstract description 3
- 230000004151 fermentation Effects 0.000 abstract description 3
- 230000003301 hydrolyzing effect Effects 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 230000002194 synthesizing effect Effects 0.000 abstract description 3
- 101710136262 2-amino-5-formylamino-6-ribosylaminopyrimidin-4(3H)-one 5'-monophosphate deformylase Proteins 0.000 abstract 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 60
- 239000004471 Glycine Substances 0.000 description 29
- 239000000047 product Substances 0.000 description 29
- ZGUNAGUHMKGQNY-SSDOTTSWSA-N D-alpha-phenylglycine Chemical compound OC(=O)[C@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-SSDOTTSWSA-N 0.000 description 10
- 238000005374 membrane filtration Methods 0.000 description 8
- 238000007670 refining Methods 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 7
- 230000036632 reaction speed Effects 0.000 description 7
- 230000002210 biocatalytic effect Effects 0.000 description 6
- 230000003197 catalytic effect Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- NXQJDVBMMRCKQG-UHFFFAOYSA-N 5-phenylimidazolidine-2,4-dione Chemical compound O=C1NC(=O)NC1C1=CC=CC=C1 NXQJDVBMMRCKQG-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- -1 carbamyl phenylglycine Chemical compound 0.000 description 4
- 239000013067 intermediate product Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- 238000001308 synthesis method Methods 0.000 description 4
- 241000157908 Paenarthrobacter aurescens Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- VSPVENBPAQWIQK-UHFFFAOYSA-N 5-(4-iodophenyl)imidazolidine-2,4-dione Chemical compound C1=CC(I)=CC=C1C1C(=O)NC(=O)N1 VSPVENBPAQWIQK-UHFFFAOYSA-N 0.000 description 2
- HLGCUXIRWKRNJF-UHFFFAOYSA-N 5-naphthalen-2-ylimidazolidine-2,4-dione Chemical compound O=C1NC(=O)NC1C1=CC=C(C=CC=C2)C2=C1 HLGCUXIRWKRNJF-UHFFFAOYSA-N 0.000 description 2
- KIRJLZYHKDPKEY-UHFFFAOYSA-N 5-pyridin-2-ylimidazolidine-2,4-dione Chemical compound O=C1NC(=O)NC1C1=CC=CC=N1 KIRJLZYHKDPKEY-UHFFFAOYSA-N 0.000 description 2
- NVIRPUHCJSOWIF-UHFFFAOYSA-N 5-pyridin-3-ylimidazolidine-2,4-dione Chemical compound O=C1NC(=O)NC1C1=CC=CN=C1 NVIRPUHCJSOWIF-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 150000008574 D-amino acids Chemical class 0.000 description 2
- 108090000604 Hydrolases Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- QGJGBYXRJVIYGA-SSDOTTSWSA-N (2r)-2-amino-2-(4-chlorophenyl)acetic acid Chemical compound OC(=O)[C@H](N)C1=CC=C(Cl)C=C1 QGJGBYXRJVIYGA-SSDOTTSWSA-N 0.000 description 1
- JKFYKCYQEWQPTM-SSDOTTSWSA-N (2r)-2-amino-2-(4-fluorophenyl)acetic acid Chemical compound OC(=O)[C@H](N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-SSDOTTSWSA-N 0.000 description 1
- APLQICUORRMFHY-SSDOTTSWSA-N (2r)-2-azaniumyl-2-(4-bromophenyl)acetate Chemical compound [O-]C(=O)[C@H]([NH3+])C1=CC=C(Br)C=C1 APLQICUORRMFHY-SSDOTTSWSA-N 0.000 description 1
- SHUIEJDVWZHDTI-SSDOTTSWSA-N (2r)-2-azaniumyl-2-(4-iodophenyl)acetate Chemical compound [O-]C(=O)[C@H]([NH3+])C1=CC=C(I)C=C1 SHUIEJDVWZHDTI-SSDOTTSWSA-N 0.000 description 1
- SQCOEUUTSVPTAE-UHFFFAOYSA-N 2h-pyridine-1-carboxamide Chemical compound NC(=O)N1CC=CC=C1 SQCOEUUTSVPTAE-UHFFFAOYSA-N 0.000 description 1
- JMRHMDVCJFYNGR-UHFFFAOYSA-N 5-(4-bromophenyl)imidazolidine-2,4-dione Chemical compound C1=CC(Br)=CC=C1C1C(=O)NC(=O)N1 JMRHMDVCJFYNGR-UHFFFAOYSA-N 0.000 description 1
- VPZYKVWVBSWFFL-UHFFFAOYSA-N 5-(4-chlorophenyl)imidazolidine-2,4-dione Chemical compound C1=CC(Cl)=CC=C1C1C(=O)NC(=O)N1 VPZYKVWVBSWFFL-UHFFFAOYSA-N 0.000 description 1
- JVJWBNDTVJFUDT-UHFFFAOYSA-N 5-(4-fluorophenyl)imidazolidine-2,4-dione Chemical compound C1=CC(F)=CC=C1C1C(=O)NC(=O)N1 JVJWBNDTVJFUDT-UHFFFAOYSA-N 0.000 description 1
- KZVRXPPUJQRGFN-UHFFFAOYSA-N N-carbamoylglycine Chemical compound NC(=O)NCC(O)=O KZVRXPPUJQRGFN-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000007210 heterogeneous catalysis Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000010983 kinetics study Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/10—Process efficiency
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
本发明涉及化工制药领域,尤其涉及一种非均相酶催化水解5-芳基海因合成D-芳基甘氨酸的方法,本发明以海因酶产生菌Arthrobacter aurescensLZ98的突变菌UV-LZ98和氨甲酰胺水解酶产生菌Agrobacteriumradiobacter LZ99的突变菌UV-LZ99发酵制备的酶制剂为催化剂,投入高出均相反应3-10倍以上量的5-芳基海因进行非均相催化反应,使产物D-芳基甘氨酸在底物被水解的过程中直接以固体方式析出,从而提高了合成效率,降低了蒸发能耗,并且产品质量稳定。
The invention relates to the field of chemical industry and pharmacy, in particular to a method for synthesizing D-arylglycine by hydrolyzing 5-arylhydantoin with heterogeneous enzyme catalysis. The enzyme preparation prepared by fermentation of the mutant bacteria UV-LZ99 of the formamide hydrolase-producing bacteria Agrobacteriumradiobacter LZ99 is used as a catalyst, and 5-arylhydantoin in an amount 3-10 times higher than that of the homogeneous reaction is put into the heterogeneous catalytic reaction to make the product The D-arylglycine is directly precipitated in a solid form during the hydrolysis process of the substrate, thereby improving the synthesis efficiency, reducing evaporation energy consumption, and stable product quality.
Description
技术领域technical field
本发明涉及化工制药领域,尤其涉及一种非均相酶催化水解5-芳基海因合成D-芳基甘氨酸的方法。The invention relates to the field of chemical industry and pharmacy, in particular to a method for synthesizing D-arylglycine by hydrolyzing 5-arylhydantoin with heterogeneous enzyme catalysis.
背景技术Background technique
D-芳基甘氨酸是一类十分重要的非天然氨基酸,由于其构型与天然氨基酸正好相反而主要用于药物、肽以及甜味剂等的合成和制备,近年来随着对其应用价值的进一步开发,市场的需求量在迅猛增长。D-arylglycine is a very important class of non-natural amino acids. Because its configuration is just opposite to that of natural amino acids, it is mainly used in the synthesis and preparation of drugs, peptides and sweeteners. In recent years, with the increase in its application value Further development, the market demand is growing rapidly.
传统的D-芳基甘氨酸的制备方法,包括了化学合成及拆分法和生物催化D-芳基海因水解法,其中所有报道的技术均为液-液均相过程,而均相生物催化水解法合成D-芳基甘氨酸因其溶解度小而导致反应体积庞大、产能低、能耗高。The traditional preparation method of D-arylglycine includes chemical synthesis and resolution method and biocatalytic D-arylhydantoin hydrolysis method, wherein all reported technologies are liquid-liquid homogeneous processes, while homogeneous biocatalysis Due to the low solubility of D-arylglycine by hydrolysis, the reaction volume is large, the production capacity is low, and the energy consumption is high.
发明内容Contents of the invention
本发明要解决的技术问题是提供一种非均相酶催化水解5-芳基海因制备D-芳基甘氨酸的方法,以克服现有技术中存在的问题。The technical problem to be solved by the present invention is to provide a method for preparing D-arylglycine by catalyzing the hydrolysis of 5-arylhydantoin with heterogeneous enzymes, so as to overcome the problems existing in the prior art.
本发明的构思是这样的:Design of the present invention is such:
在应用化学合成的方法制备底物5-芳基海因的基础上,以海因酶产生菌Arthrobacter aurescens LZ98的突变菌UV-LZ98和氨甲酰胺水解酶产生菌Agrobacterium radiobacter LZ99的突变菌UV-LZ99混合发酵制备的酶制剂为催化剂,投入高出均相反应3-10倍以上量的5-芳基海因进行非均相催化反应,使产物D-芳基甘氨酸以固体的方式随底物被水解直接获得,以提高生产效率和降低蒸发能耗。On the basis of preparing the substrate 5-arylhydantoin by chemical synthesis, the mutant strain UV-LZ98 of Arthrobacter aurescens LZ98 and the mutant strain of Agrobacterium radiobacter LZ99 produced by hydantoinase were used The enzyme preparation prepared by mixed fermentation of LZ99 is used as a catalyst, and 5-arylhydantoin is put into the heterogeneous catalytic reaction in an amount 3-10 times higher than that of the homogeneous reaction, so that the product D-arylglycine is mixed with the substrate in a solid form. It is directly obtained by hydrolysis to improve production efficiency and reduce evaporation energy consumption.
本发明中D-芳基甘氨酸包括D-苯甘氨酸、D-氟苯甘氨酸、D-氯苯甘氨酸、D-溴苯甘氨酸、D-碘苯甘氨酸、D-烷氧苯甘氨酸、D-吡啶甘氨酸、D-萘甘氨酸、D-喹啉甘氨酸、D-嘧啶甘氨酸、D-吡嗪甘氨酸、D-哒嗪甘氨酸、D-吲哚甘氨酸、D-噻吩甘氨酸、D-呋喃甘氨酸、D-吡咯甘氨酸、D-吡唑甘氨酸、D-咪唑甘氨酸、D-噻唑甘氨酸、D-噁唑甘氨酸和D-异噁唑甘氨酸等,其中D-喹啉甘氨酸系列中大部分为新化合物,甘氨酸α碳可连在芳环的不同环碳上。In the present invention, D-arylglycine includes D-phenylglycine, D-fluorophenylglycine, D-chlorophenylglycine, D-bromophenylglycine, D-iodophenylglycine, D-alkoxyphenylglycine, D-pyridineglycine, D-naphthylglycine, D-quinolineglycine, D-pyrimidineglycine, D-pyrazineglycine, D-pyridazineglycine, D-indoleglycine, D-thiopheneglycine, D-furanglycine, D-pyrroleglycine, D -Pyrazole glycine, D-imidazole glycine, D-thiazole glycine, D-oxazole glycine and D-isoxazole glycine, etc. Most of the D-quinoline glycine series are new compounds, and the α carbon of glycine can be connected to aromatic on different ring carbons of the ring.
本发明根据酶制剂酶活的高低,调整反应温度和反应压力,可以控制反应速度和产品结晶速度,避免底物海因被包夹。According to the enzyme activity of the enzyme preparation, the present invention adjusts the reaction temperature and the reaction pressure, can control the reaction speed and the crystallization speed of the product, and avoid the substrate hydantoin being trapped.
本发明的技术解决方案为:Technical solution of the present invention is:
本发明非均相酶催化水解5-芳基海因合成D-芳基甘氨酸的方法,包括以下步骤:The method for synthesizing D-arylglycine by heterogeneous enzyme catalyzed hydrolysis of 5-aryl hydantoin of the present invention comprises the following steps:
①在生物催化水解反应器中,依次投入溶剂水、5-芳基海因、酶制剂、酸或碱等,搅拌形成悬浮液,5-芳基海因的投入量为反应体系物料总量的5~21%(w/w),加酸调pH值为6.5~7.8;①In the biocatalytic hydrolysis reactor, add solvent water, 5-aryl hydantoin, enzyme preparation, acid or alkali, etc. in sequence, and stir to form a suspension. 5-21% (w/w), adding acid to adjust the pH value to 6.5-7.8;
②按反应液质量总量的2~8%、酶活为0.28U/mL以上的酶制剂投入到上述生物催化水解反应器中,控制温度在25~40℃,开始搅拌反应;② Put 2-8% of the total mass of the reaction liquid into the above-mentioned biocatalytic hydrolysis reactor with an enzyme preparation with an enzyme activity of 0.28 U/mL or more, control the temperature at 25-40°C, and start the stirring reaction;
③在反应过程中,控制反应系统压力在0.09~0.03Mpa之间,间隔6h取样,用液相色谱法检测反应情况,当反应进行到8h左右时,则有D-芳基甘氨酸晶体开始析出,待反应体系中检不出底物5-芳基海因时,反应基本结束;③ During the reaction process, control the pressure of the reaction system between 0.09 and 0.03Mpa, take samples at intervals of 6 hours, and use liquid chromatography to detect the reaction situation. When the reaction lasts for about 8 hours, D-arylglycine crystals begin to precipitate. When the substrate 5-arylhydantoin cannot be detected in the reaction system, the reaction is basically finished;
④筛分分离得到的粗晶经过重结晶便可获得产品D-芳基甘氨酸。④ The coarse crystals obtained by screening and separation can be recrystallized to obtain the product D-arylglycine.
所述酶制剂溶液的制备方法为:Arthrobacter aurescens LZ98的突变菌UV-LZ98和Agrobacterium radiobacter LZ99的突变菌UV-LZ99混合发酵制得含有海因酶和氨甲酰胺水解酶的酶制剂,即“两菌两酶”。The preparation method of the enzyme preparation solution is as follows: the mutant bacteria UV-LZ98 of Arthrobacter aurescens LZ98 and the mutant bacteria UV-LZ99 of Agrobacterium radiobacter LZ99 are mixed and fermented to obtain an enzyme preparation containing hydantoinase and carbaamide hydrolase, namely "two Bacterial enzymes".
进一步的,所述D-芳基甘氨酸为D-苯甘氨酸、D-氟苯甘氨酸、D-氯苯甘氨酸、D-溴苯甘氨酸、D-碘苯甘氨酸、D-甲氧苯甘氨酸、D-吡啶甘氨酸、D-萘甘氨酸、D-喹啉甘氨酸、D-嘧啶甘氨酸、D-吡嗪甘氨酸、D-哒嗪甘氨酸、D-吲哚甘氨酸、D-噻吩甘氨酸、D-呋喃甘氨酸、D-吡咯甘氨酸、D-吡唑甘氨酸、D-咪唑甘氨酸、D-噻唑甘氨酸、D-噁唑甘氨酸和D-异噁唑甘氨酸等D-氨基酸中的一种,其中甘氨酸α碳可连在芳环不同位置的碳原子上。Further, the D-arylglycine is D-phenylglycine, D-fluorophenylglycine, D-chlorophenylglycine, D-bromophenylglycine, D-iodophenylglycine, D-methoxyphenylglycine, D-pyridine Glycine, D-naphthylglycine, D-quinolineglycine, D-pyrimidineglycine, D-pyrazineglycine, D-pyridazineglycine, D-indoleglycine, D-thiopheneglycine, D-furanglycine, D-pyrroleglycine , D-pyrazole glycine, D-imidazole glycine, D-thiazole glycine, D-oxazole glycine and D-isoxazole glycine and other D-amino acids, wherein the α carbon of glycine can be connected to different positions of the aromatic ring on the carbon atom.
进一步的,所述D-芳基甘氨酸为D-苯甘氨酸,其合成方法包括以下步骤:Further, the D-arylglycine is D-phenylglycine, and its synthesis method comprises the following steps:
①在10L酶催化反应罐中,加入水7kg、5-苯基海因0.9~1kg、加盐酸或硫酸调整pH到6.8;①In a 10L enzyme-catalyzed reaction tank, add 7kg of water, 0.9-1kg of 5-phenylhydantoin, and add hydrochloric acid or sulfuric acid to adjust the pH to 6.8;
②在搅拌的条件下再加入湿的酶活为0.62U/ml的酶制剂溶液酶活为0.3L,控制温度为25~38℃下,搅拌反应;②Add wet enzyme preparation solution with 0.62U/ml enzyme activity under stirring condition, then add 0.3L of enzyme activity, control the temperature at 25-38℃, and stir to react;
③间隔6h取样,用液相色谱法检测反应情况,当反应进行到8h左右时,则有D-苯甘氨酸晶体开始析出,待反应体系中检不出底物5-苯基海因,且N-氨甲酰苯甘氨酸0.25%以下时,反应基本结束;③ Sampling at intervals of 6 hours, using liquid chromatography to detect the reaction, when the reaction lasted for about 8 hours, D-phenylglycine crystals began to precipitate, and the substrate 5-phenylhydantoin was not detected in the reaction system, and N - when carbamyl phenylglycine is below 0.25%, the reaction is basically finished;
④分离得到的粗晶经过重结晶便可获得合格产品D-苯甘氨酸;④ The separated coarse crystals can be recrystallized to obtain the qualified product D-phenylglycine;
⑤透析过筛孔的料液,分别采用膜过滤、浓缩等提炼过程可获得溶液中另一部分D-苯甘氨酸。⑤ Dialyze the feed liquid through the sieve holes, and use membrane filtration, concentration and other refining processes to obtain another part of D-phenylglycine in the solution.
进一步的,所述D-芳基甘氨酸为D-吡啶甘氨酸,其合成方法包括以下步骤:Further, the D-arylglycine is D-pyridineglycine, and its synthesis method comprises the following steps:
①在10L酶催化反应罐中,加入水6.5kg,搅拌下投入5-吡啶基海因1kg,加盐酸或硫酸调整pH到6.5;①In a 10L enzyme-catalyzed reaction tank, add 6.5kg of water, add 1kg of 5-pyridylhydantoin under stirring, add hydrochloric acid or sulfuric acid to adjust the pH to 6.5;
②再加入湿的酶活为0.58U/ml的酶制剂溶液约0.4L,控制温度为28~36℃下搅拌反应;②Add about 0.4L of wet enzyme preparation solution with an enzyme activity of 0.58U/ml, and stir the reaction at a controlled temperature of 28-36°C;
③间隔8h取样,用液相色谱法检测反应情况,当反应进行到9h左右时,则有D-吡啶甘氨酸晶体开始析出。待反应体系中检不出底物5-吡啶基海因,且N-氨甲酰-D-吡啶甘氨酸0.20%以下时,反应基本结束;③ Sampling was taken at intervals of 8 hours, and the reaction was detected by liquid chromatography. When the reaction lasted for about 9 hours, D-pyridine glycine crystals began to precipitate. When the substrate 5-pyridylhydantoin cannot be detected in the reaction system, and the N-carbamoyl-D-pyridine glycine is below 0.20%, the reaction is basically completed;
④分离得到的粗晶经过重结晶便可获得合格产品D-吡啶甘氨酸。④ The separated coarse crystals can be recrystallized to obtain the qualified product D-pyridine glycine.
⑤透析过筛孔的料液,分别采用膜过滤、浓缩等提炼过程可获得溶液中另一部分D-吡啶甘氨酸。⑤ Dialyze the feed liquid through the sieve holes, and use membrane filtration, concentration and other refining processes to obtain another part of D-pyridine glycine in the solution.
进一步的,所述D-芳基甘氨酸为D-萘甘氨酸,其合成方法包括以下步骤:Further, the D-arylglycine is D-naphthylglycine, and its synthesis method comprises the following steps:
①在10L酶催化反应罐中,加入水7.5kg,搅拌下投入5-萘基海因0.8kg、加盐酸或硫酸调整pH到7.0;①In a 10L enzyme-catalyzed reaction tank, add 7.5kg of water, add 0.8kg of 5-naphthylhydantoin under stirring, add hydrochloric acid or sulfuric acid to adjust the pH to 7.0;
②在搅拌的条件下再加入湿的酶活为0.62U/ml的酶制剂溶液酶活为0.4L,控制温度为30~40℃下,搅拌反应;②Add wet enzyme preparation solution with an enzyme activity of 0.62U/ml under the condition of stirring.
③间隔8h取样,用液相色谱法检测反应情况,当反应进行到7h左右时,则有D-萘甘氨酸晶体开始析出,待反应体系中检不出底物5-萘基海因以及对应的中间体时,反应基本结束;③Sampling at intervals of 8 hours, using liquid chromatography to detect the reaction situation, when the reaction proceeds to about 7 hours, D-naphthylglycine crystals begin to precipitate, and the substrate 5-naphthylhydantoin and the corresponding intermediate, the reaction is basically over;
④筛分分离得到的粗晶经过重结晶便可获得合格产品D-萘甘氨酸。④ The coarse crystals obtained by screening and separation can be recrystallized to obtain the qualified product D-naphthylglycine.
⑤透析过筛孔的料液,分别采用膜过滤、浓缩等提炼过程可获得溶液中另一部分D-萘甘氨酸。⑤ Dialyze the feed liquid through the sieve holes, and use membrane filtration, concentration and other refining processes to obtain another part of D-naphthylglycine in the solution.
进一步的,所述D-芳基甘氨酸为D-喹啉甘氨酸,其合成方法包括以下步骤:Further, the D-arylglycine is D-quinolineglycine, and its synthesis method comprises the following steps:
①在10L酶催化反应罐中,加入水8kg,在搅拌的条件下投入5-喹啉海因0.85kg,调整pH到6.5;①In a 10L enzyme-catalyzed reaction tank, add 8 kg of water, add 0.85 kg of 5-quinoline hydantoin under stirring conditions, and adjust the pH to 6.5;
②然后加入湿的酶活为0.68U/ml的酶制剂溶液约0.35L,于35~38℃下搅拌反应;② Then add about 0.35L of wet enzyme preparation solution with an enzyme activity of 0.68U/ml, and stir and react at 35-38°C;
③间隔6h取样,用液相色谱法检测反应情况,当反应进行到8h左右时,则有D-喹啉甘氨酸晶体开始析出,待反应体系中检不出底物5-喹啉海因,且N-氨甲酰-D-喹啉甘氨酸低于0.30%时,反应基本结束;③Sampling at intervals of 6 hours, using liquid chromatography to detect the reaction situation, when the reaction was carried out to about 8 hours, D-quinoline glycine crystals began to precipitate, and the substrate 5-quinoline hydantoin was not detected in the reaction system, and When N-carbamoyl-D-quinoline glycine is lower than 0.30%, the reaction is basically finished;
④筛分分离得到的粗晶经过重结晶便可获得合格产品D-2-喹啉甘氨酸。④ The coarse crystals obtained by screening and separation can be recrystallized to obtain the qualified product D-2-quinolineglycine.
⑤透析过筛孔的料液,分别采用膜过滤、浓缩等提炼过程可获得溶液中另一部分D-喹啉甘氨酸。⑤ Dialyze the feed liquid through the sieve holes, and use membrane filtration, concentration and other refining processes to obtain another part of D-quinoline glycine in the solution.
本发明的非均相催化是在微生物为催化剂的前提下实现的,更重要的是反应物和大部分的产物在整个过程中均为固相,通过条件的控制避免了固体的包夹,使转化率达到了99.5%以上。The heterogeneous catalysis of the present invention is realized on the premise that microorganisms are catalysts, and more importantly, the reactants and most of the products are in the solid phase throughout the process, and the entrapment of solids is avoided through the control of conditions, so that The conversion rate has reached more than 99.5%.
本发明中,5-芳基海因生物催化制备D-芳基甘氨酸经过两步反应。第一步是底物5-芳基海因在海因酶催化下被水解为中间产物D-N-氨甲酰-芳基甘氨酸;第二步是中间产物在氨甲酰胺水解酶催化下被水解为产物D-芳基甘氨酸。In the present invention, the biocatalytic preparation of D-arylglycine by 5-aryl hydantoin undergoes two-step reactions. The first step is that the substrate 5-arylhydantoin is hydrolyzed to the intermediate product D-N-carbamoyl-arylglycine under the catalysis of hydantoinase; the second step is that the intermediate product is hydrolyzed to The product D-arylglycine.
酶的催化作用是一个复杂的过程,受酶分子的结构、酶与底物分子相互作用、酶与底物的定向效应、酶与底物的手性选择结合和与反应过渡态的结合等作用的影响。在实际应用中金属离子对酶催化能力产生着重要的作用,Ni、Cu等二价离子有抑制作用,而Mn、Mg等二价离子则有明显的激活作用。The catalysis of enzymes is a complex process, which is affected by the structure of enzyme molecules, the interaction between enzymes and substrate molecules, the directional effect of enzymes and substrates, the chiral selective binding of enzymes and substrates, and the combination with reaction transition states. Impact. In practical applications, metal ions play an important role in the catalytic ability of enzymes. Divalent ions such as Ni and Cu have inhibitory effects, while divalent ions such as Mn and Mg have obvious activation effects.
酶催化5-芳基海因水解制备D-芳基甘氨酸的动力学研究表明,在酶浓度固定、基本条件不变的前提下,底物浓度较低时,反应基本表现出一级反应,然而当反应物浓度增大到饱和后,反应速度趋于恒定,达到最大。如果能保证体系中底物5-芳基海因的浓度在相当长时间里处于饱和状态,那么就可以使酶催化反应速度在相当长的时间里维持最大值。在酶制剂的酶活达到足够高的前提下,在水存在的反应系统中,固态(没有完全形成溶液)底物5-芳基海因随着溶液中溶质底物被催化水解生成产物的同时快速溶解以使溶液始终处于饱和态而保证酶促反应以最高速度进行。与此同时,生成的产物随着浓度的增加达到饱和后,将以晶体的形式结晶出来,打破了溶解平衡,使酶促反应能顺利地进行,从而实现非均相生物催化水解5-芳基海因合成D-芳基甘氨酸的过程。The kinetics study of enzyme-catalyzed hydrolysis of 5-arylhydantoin to D-arylglycine showed that under the premise that the enzyme concentration was fixed and the basic conditions were unchanged, the reaction basically showed a first-order reaction when the substrate concentration was low. When the concentration of reactants increases to saturation, the reaction rate tends to be constant and reaches a maximum. If it can be ensured that the concentration of the substrate 5-arylhydantoin in the system is in a saturated state for a long time, then the enzyme-catalyzed reaction speed can be maintained at the maximum value for a long time. Under the premise that the enzyme activity of the enzyme preparation reaches a high enough level, in the reaction system in the presence of water, the solid state (not completely forming a solution) substrate 5-arylhydantoin is catalyzed and hydrolyzed to produce products while the solute substrate in the solution is hydrolyzed. Rapid dissolution keeps the solution in a saturated state and ensures that the enzymatic reaction proceeds at the highest speed. At the same time, the generated product will crystallize out in the form of crystals after reaching saturation with the increase of concentration, which breaks the dissolution balance and enables the enzymatic reaction to proceed smoothly, thereby realizing the heterogeneous biocatalytic hydrolysis of 5-aryl Hydantoin synthesis of D-arylglycine.
传统的“一菌两酶”法可在一个细胞内完成整个转化、水解过程,而“两菌两酶”法则是在两个不同细胞中完成的。因此,底物、中间体和产物在不同细胞之间的传质过程是本技术的关键。为了降低传质对反应速度的影响,加入阳离子表面活性剂于反应体系则可取得良好的结果。The traditional "one bacterium, two enzymes" method can complete the entire transformation and hydrolysis process in one cell, while the "two bacteria, two enzymes" method is completed in two different cells. Therefore, the mass transfer process of substrates, intermediates and products between different cells is the key to this technology. In order to reduce the influence of mass transfer on the reaction rate, good results can be obtained by adding cationic surfactants to the reaction system.
非均相生物催化过程有别于化学催化过程,但生物催化剂的催化活性同样随着反应时间的延长存在下降的问题。因此,控制底物的总投料量是必要的。本发明中确定底物5-芳基海因的量占反应物系总量的5~18%比较合适,而不同芳基有不同的理想值。这里的量值比例为质量比,反应物体系包含水、酶制剂、酸(硫酸或盐酸、磷酸等)、碱(氢氧化钠、氢氧化钾、碳酸钠或其他碳酸盐等)、5-芳基海因和其他助剂等。The heterogeneous biocatalytic process is different from the chemical catalytic process, but the catalytic activity of the biocatalyst also declines with the prolongation of the reaction time. Therefore, it is necessary to control the total feeding amount of the substrate. In the present invention, it is more appropriate to determine that the amount of the substrate 5-arylhydantoin accounts for 5-18% of the total amount of the reactant system, and different aryl groups have different ideal values. The amount ratio here is mass ratio, and the reactant system includes water, enzyme preparation, acid (sulfuric acid or hydrochloric acid, phosphoric acid, etc.), alkali (sodium hydroxide, potassium hydroxide, sodium carbonate or other carbonates, etc.), 5- Aryl hydantoin and other additives, etc.
两菌两酶非均相法实施的过程中,未反应的固体底物5-芳基海因、中间产物N-氨甲酰-芳基甘氨酸固体和产品D-芳基甘氨酸固体共处同一反应器中,整个过程存在多相。而且固体中间产物D-N-氨甲酰-芳基甘氨酸和固体产品D-芳基甘氨酸是在大量底物存在的条件下形成的,极易出现相互包裹或包夹而导致转化率降低的问题。但有利的是底物的固体为粉末,而D-芳基甘氨基酸则为晶体。控制D-芳基甘氨基酸晶体析出的速度,将能避免固体相互包裹,转化率能达到99.6%以上。具体的方法是反应条件的优化、控制以及酶制剂酶活的调整。During the implementation of the two-bacteria and two-enzyme heterogeneous method, the unreacted solid substrate 5-arylhydantoin, the intermediate product N-carbamoyl-arylglycine solid and the product D-arylglycine solid co-exist in the same reactor In , there are multiple phases in the whole process. Moreover, the solid intermediate product D-N-carbamoyl-arylglycine and the solid product D-arylglycine are formed under the conditions of the presence of a large amount of substrates, and the problem of mutual wrapping or trapping is very easy to cause the conversion rate to decrease. Advantageously, however, the solids of the substrates are powders and the D-arylglycamino acids are crystalline. Controlling the precipitation speed of D-arylglycyl amino acid crystals will prevent solids from wrapping each other, and the conversion rate can reach more than 99.6%. The specific method is the optimization and control of the reaction conditions and the adjustment of the enzyme activity of the enzyme preparation.
pH的影响。根据催化反应原理,在转化过程中有氨气、二氧化碳及D-芳基甘氨酸产生。生成的氨易与氨基酸形成盐而在反应系统中积累,使反应后期的pH快速升高到8.5,从而强烈地抑制了N-氨甲酰胺水解酶的催化活性,导致反应速度减慢,甚至停止。所以适时控制酸碱性对反应十分重要,6.5-7.8是适宜的pH。The effect of pH. According to the principle of catalytic reaction, ammonia, carbon dioxide and D-arylglycine are produced during the conversion process. The generated ammonia easily forms salts with amino acids and accumulates in the reaction system, causing the pH in the later stage of the reaction to rise rapidly to 8.5, thereby strongly inhibiting the catalytic activity of N-aminocarboxamide hydrolase, resulting in a slowdown or even stop of the reaction . Therefore, it is very important to control the acidity and alkalinity in time for the reaction, and 6.5-7.8 is the appropriate pH.
温度对反应的影响。在浓度、pH固定的条件下,温度对酶催化反应速度也有较大的影响。温度在25℃时,反应速度较慢,但产品晶体析出速度也较慢,有利于晶核的长大,包裹现象几乎观测不到;随着反应温度的提高反应速度也加快,当达到41℃时,反应速度很快,在过饱和体系中晶核形成速度也随着加快,包裹现象趋于明显。适宜的温度为25-40℃。The effect of temperature on the reaction. Under the conditions of fixed concentration and pH, temperature also has a great influence on the rate of enzyme-catalyzed reaction. When the temperature is 25°C, the reaction speed is slow, but the crystallization speed of the product is also slow, which is conducive to the growth of the crystal nucleus, and the encapsulation phenomenon is almost invisible; as the reaction temperature increases, the reaction speed also accelerates, and when it reaches 41°C When , the reaction speed is very fast, and the crystal nucleus formation speed is also accelerated in the supersaturated system, and the encapsulation phenomenon tends to be obvious. A suitable temperature is 25-40°C.
本发明与现有技术相比具有以下显著优点:Compared with the prior art, the present invention has the following significant advantages:
1、选用两株不同的菌,使其各产生一种酶,形成“两菌两酶”催化体系,不仅可最大限度地加快反应速度,同时也使两步催化水解一次完成。较原有“一菌两酶”技术极大地提高了反应速度。1. Select two different strains of bacteria to produce an enzyme each to form a "two bacteria and two enzymes" catalytic system, which can not only speed up the reaction speed to the greatest extent, but also complete the two-step catalytic hydrolysis at one time. Compared with the original "one bacteria, two enzymes" technology, the reaction speed is greatly improved.
2、5-芳基海因的投入量为传统工艺的3-10倍,且远高于其溶解度。随着反应的进行,产物D-芳基甘氨酸将积累直至晶体析出,一次晶体产出率可达到总产物量的40-75%(w/w),减少了浓缩蒸发蒸汽的消耗量,节能率在40%以上。2. The input amount of 5-arylhydantoin is 3-10 times that of the traditional process, and it is much higher than its solubility. As the reaction proceeds, the product D-arylglycine will accumulate until the crystals are precipitated, and the yield of crystals at one time can reach 40-75% (w/w) of the total product amount, reducing the consumption of concentrated evaporation steam and saving energy. Above 40%.
3、产品质量稳定,减少一次水的用量,产率高出原有工艺4个百分点以上。3. The product quality is stable, the amount of primary water is reduced, and the yield is higher than the original process by more than 4 percentage points.
附图说明Description of drawings
图1为D-氨基酸的结构图;Fig. 1 is the structural diagram of D-amino acid;
图2为5-芳基海因酶催化水解制备D-芳基甘氨酸的反应原理图。Fig. 2 is a schematic diagram of the reaction for preparing D-arylglycine by enzymatic hydrolysis of 5-arylhydantoin.
说明:图1中的R为芳基;图2中R与图1中R相同。Explanation: R in Figure 1 is an aryl group; R in Figure 2 is the same as R in Figure 1.
具体实施方式Detailed ways
下面对本发明作进一步的说明。The present invention will be further described below.
首先以海因酶产生菌Arthrobacter aurescens LZ98的突变菌UV-LZ98和氨甲酰胺水解酶产生菌Agrobacterium radiobacter LZ99的突变菌UV-LZ99混合发酵制备得酶制剂。然后完成本发明过程。Firstly, the enzyme preparation is prepared by mixed fermentation of hydantoinase-producing bacteria Arthrobacter aurescens LZ98 mutant bacteria UV-LZ98 and carbamidase-producing bacteria Agrobacterium radiobacter LZ99 mutant bacteria UV-LZ99. The process of the invention is then completed.
实施例1,D-苯甘氨酸的制备
在10L酶催化反应罐中,先加入7kg水,然后投入5-苯基海因1kg,加盐酸或硫酸调整pH到6.8,在搅拌的条件下再加入湿的酶活为0.62U/ml的酶制剂溶液约0.3L,控制温度为28℃,搅拌反应。间隔6h取样,用液相色谱法检测反应情况,当反应进行到8h左右时,则有D-苯甘氨酸晶体开始析出,反应液中产品浓度基本恒定在2.45%。待反应体系中检不出底物5-苯基海因,且N-氨甲酰苯甘氨酸0.25%以下时,反应基本结束,其转化率在99.6%以上。筛分分离得到的粗晶,经过重结晶便可获得合格产品D-苯甘氨酸446.2g;透析过筛孔的物料则采用膜过滤、浓缩等提炼过程获得另一部分D-苯甘氨酸产品240.2g。共得到产品686.4g,收率为80%。In a 10L enzyme-catalyzed reaction tank, first add 7kg of water, then add 1kg of 5-phenylhydantoin, add hydrochloric acid or sulfuric acid to adjust the pH to 6.8, and then add wet enzyme activity of 0.62U/ml under stirring conditions The preparation solution is about 0.3L, the temperature is controlled at 28°C, and the reaction is stirred. Samples were taken at intervals of 6 hours, and the reaction was detected by liquid chromatography. When the reaction lasted for about 8 hours, D-phenylglycine crystals began to precipitate, and the product concentration in the reaction solution was basically constant at 2.45%. When the substrate 5-phenylhydantoin cannot be detected in the reaction system and the N-carbamoylglycine is below 0.25%, the reaction is basically completed, and the conversion rate is above 99.6%. The crude crystals obtained by sieving and separation can be recrystallized to obtain 446.2g of qualified product D-phenylglycine; the material that has passed through the sieve is obtained by membrane filtration, concentration and other refining processes to obtain another part of D-phenylglycine product 240.2g. A total of 686.4 g of the product was obtained with a yield of 80%.
D-对氟苯甘氨酸可由5-对氟苯基海因水解获得,制法与实施例1相似,收率77%。D-p-fluorophenylglycine can be obtained by hydrolysis of 5-p-fluorophenylhydantoin, the preparation method is similar to that of Example 1, and the yield is 77%.
D-对氯苯甘氨酸可由5-对氯苯基海因水解获得,制法与实施例1相同,收率81%。D-p-chlorophenylglycine can be obtained by hydrolysis of 5-p-chlorophenylhydantoin, the preparation method is the same as that of Example 1, and the yield is 81%.
D-对溴苯甘氨酸可由5-对溴苯基海因水解获得,制法与实施例1相似,相同,收率73%。D-p-bromophenylglycine can be obtained by hydrolysis of 5-p-bromophenylhydantoin, the preparation method is similar to that of Example 1, the yield is 73%.
D-对碘苯甘氨酸制可由5-对碘苯基海因水解获得,制法与实施例1相似,收率69%。D-p-iodophenylglycine can be obtained by hydrolysis of 5-p-iodophenylhydantoin, the preparation method is similar to that of Example 1, and the yield is 69%.
D-对甲氧苯甘氨酸制法可由5-对碘苯基海因水解获得,制法与实施例1相同,收率75%。The preparation method of D-methoxyphenylglycine can be obtained by hydrolyzing 5-p-iodophenylhydantoin, and the preparation method is the same as that of Example 1, and the yield is 75%.
实施例2,D-3-吡啶甘氨酸制备Embodiment 2, preparation of D-3-pyridine glycine
在10L的酶催化反应罐中,先加入6.5kg水,在搅拌的条件下投入5-(3-吡啶基)海因1kg,调整pH到6.5,然后加入湿的酶活为0.58U/ml的酶制剂溶液约0.4L,于32~36℃下搅拌反应。间隔8h取样,用液相色谱法检测反应情况,当反应进行到9h左右时,则有D-吡啶甘氨酸晶体开始析出。待反应体系中检不出底物5-(3-吡啶基)海因,且N-氨甲酰吡啶甘氨酸0.20%以下时,反应基本结束,其转化率在99.5%左右。筛分分离得到的粗晶经过重结晶便可获得合格产品D-3-吡啶甘氨酸391.6g;透析过筛孔的物料则采用膜过滤、浓缩等提炼过程获得另一部分产品261.1g。共计产品652.7g,收率为76%。In a 10L enzyme-catalyzed reaction tank, first add 6.5kg of water, add 1kg of 5-(3-pyridyl)hydantoin under stirring conditions, adjust the pH to 6.5, and then add wet enzyme activity of 0.58U/ml Enzyme preparation solution is about 0.4L, stirred and reacted at 32-36°C. Samples were taken at intervals of 8 hours, and the reaction was detected by liquid chromatography. When the reaction lasted for about 9 hours, D-pyridine glycine crystals began to precipitate. When the substrate 5-(3-pyridyl)hydantoin cannot be detected in the reaction system and the N-carbamoylpyridine glycine is below 0.20%, the reaction is basically completed, and the conversion rate is about 99.5%. The coarse crystals obtained by sieving and separation can be recrystallized to obtain 391.6 g of qualified product D-3-pyridine glycine; the material that has passed through the sieve is obtained by membrane filtration, concentration and other refining processes to obtain another part of product 261.1 g. A total of 652.7g of the product, the yield is 76%.
其它D-吡啶甘氨酸制法基本相同。Other D-pyridine glycine preparation methods are basically the same.
实施例3,D-2-萘甘氨酸的制备Embodiment 3, the preparation of D-2-naphthylglycine
在10L的酶催化反应罐中,先加入7.5kg水,在搅拌的条件下投入5-(2-萘基)海因0.8kg,调整pH到7.0,然后加入湿的酶活为0.65U/ml的酶制剂溶液约0.4L,于30-40℃下搅拌反应。间隔8h取样,用液相色谱法检测反应情况,当反应进行到7h左右时,则有D-2-萘甘氨酸晶体开始析出。待反应体系中检不出5-(2-萘基)海因以及对应的中间体时,反应基本结束,其转化率在99%左右。筛分分离得到的粗晶经过重结晶便可获得合格产品D-2-萘甘氨酸327.3g;透析过筛孔的物料则采用膜过滤、浓缩等提炼过程获得另一部分D-2-萘甘氨酸192.2g。产品共计519.5g,收率为73%。In a 10L enzyme-catalyzed reaction tank, first add 7.5kg of water, add 0.8kg of 5-(2-naphthyl)hydantoin under stirring conditions, adjust the pH to 7.0, and then add wet enzyme activity to 0.65U/ml The enzyme preparation solution is about 0.4L, and the reaction is stirred at 30-40°C. Samples were taken at intervals of 8 hours, and the reaction was detected by liquid chromatography. When the reaction was carried out to about 7 hours, D-2-naphthylglycine crystals began to precipitate. When no 5-(2-naphthyl)hydantoin and corresponding intermediates can be detected in the reaction system, the reaction is basically finished, and the conversion rate is about 99%. The coarse crystals obtained by sieving and separation can be recrystallized to obtain 327.3g of qualified product D-2-naphthylglycine; the material that has passed through the sieve is obtained by membrane filtration, concentration and other refining processes to obtain another part of D-2-naphthylglycine 192.2g . The total product is 519.5g, and the yield is 73%.
其它D-萘甘氨酸制法基本相同。Other D-naphthylglycine preparation methods are basically the same.
实施例4,D-2-喹啉甘氨酸的制备Embodiment 4, the preparation of D-2-quinoline glycine
在10L的酶催化反应罐中,先加入8kg水,在搅拌的条件下投入5-(2-喹啉基)海因0.85kg,调整pH到6.5,然后加入湿的酶活为0.68U/ml的酶制剂溶液约0.35L,于35~38℃下搅拌反应。间隔6h取样,用液相色谱法检测反应情况,当反应进行到8h左右时,则有D-2-喹啉甘氨酸晶体开始析出。待反应体系中检不出底物5-(2-喹啉基)海因,且N-氨甲酰-D-2-喹啉甘氨酸低于0.30%时,反应基本结束,其转化率在99%左右。筛分分离得到的粗晶经过重结晶便可获得合格产品D-2-喹啉甘氨酸346.1g;透析过筛孔的物料则采用膜过滤、浓缩等提炼过程获得另一部分产品D-2-喹啉甘氨酸221.2g。产品共计567.3g,收率为75%。In a 10L enzyme-catalyzed reaction tank, first add 8kg of water, add 0.85kg of 5-(2-quinolyl)hydantoin under stirring conditions, adjust the pH to 6.5, and then add wet enzyme activity to 0.68U/ml The enzyme preparation solution is about 0.35L, and the reaction is stirred at 35-38°C. Samples were taken at intervals of 6 hours, and the reaction was detected by liquid chromatography. When the reaction lasted for about 8 hours, D-2-quinoline glycine crystals began to precipitate. When the substrate 5-(2-quinolyl)hydantoin cannot be detected in the reaction system, and N-carbamoyl-D-2-quinoline glycine is lower than 0.30%, the reaction is basically completed, and the conversion rate is 99% %about. The coarse crystals obtained by sieving and separation can be recrystallized to obtain 346.1g of qualified product D-2-quinoline glycine; the material that has passed through the sieve is obtained by membrane filtration, concentration and other refining processes to obtain another part of product D-2-quinoline Glycine 221.2g. The total product is 567.3g, and the yield is 75%.
其它D-喹啉甘氨酸制法与之基本相同。Other D-quinoline glycine production methods are basically the same.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710062118A CN101104862B (en) | 2007-06-06 | 2007-06-06 | Synthesis of D-arylglycine by heterogeneous enzyme-catalyzed hydrolysis of 5-arylhydantoin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710062118A CN101104862B (en) | 2007-06-06 | 2007-06-06 | Synthesis of D-arylglycine by heterogeneous enzyme-catalyzed hydrolysis of 5-arylhydantoin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101104862A CN101104862A (en) | 2008-01-16 |
| CN101104862B true CN101104862B (en) | 2010-05-19 |
Family
ID=38998941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200710062118A Expired - Fee Related CN101104862B (en) | 2007-06-06 | 2007-06-06 | Synthesis of D-arylglycine by heterogeneous enzyme-catalyzed hydrolysis of 5-arylhydantoin |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101104862B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101906408B (en) * | 2010-05-25 | 2013-04-17 | 河北科技大学 | Enzyme preparation for synthesizing D-aryl glycine through biocatalysis and preparation method and application thereof |
| CN102352389A (en) * | 2011-09-29 | 2012-02-15 | 重庆邮电大学 | Chemical enzyme method for preparing L-para fluobenzene glycine |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1275723A1 (en) * | 2001-07-10 | 2003-01-15 | Ajinomoto Co., Inc. | Recombinant D-hydantoin hydrolases and N-carbamyl-D-amino acid hydrolases, and DNA encoding them; uses thereof for producing D-amino acids |
| CN1431295A (en) * | 2002-12-30 | 2003-07-23 | 南京工业大学 | Method for preparing series D-a-amino acids by using Burkholderia cepacia JS-02 |
| CN1928103A (en) * | 2006-08-30 | 2007-03-14 | 石家庄经济技术开发区中天化工有限责任公司 | Method of producing D-p-hydroxy-phenyl glycine by heterogeneous enzyme catalysis method |
-
2007
- 2007-06-06 CN CN200710062118A patent/CN101104862B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1275723A1 (en) * | 2001-07-10 | 2003-01-15 | Ajinomoto Co., Inc. | Recombinant D-hydantoin hydrolases and N-carbamyl-D-amino acid hydrolases, and DNA encoding them; uses thereof for producing D-amino acids |
| CN1431295A (en) * | 2002-12-30 | 2003-07-23 | 南京工业大学 | Method for preparing series D-a-amino acids by using Burkholderia cepacia JS-02 |
| CN1928103A (en) * | 2006-08-30 | 2007-03-14 | 石家庄经济技术开发区中天化工有限责任公司 | Method of producing D-p-hydroxy-phenyl glycine by heterogeneous enzyme catalysis method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101104862A (en) | 2008-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8034975B2 (en) | Method of manufacturing succinic acid and ammonium succinate solutions | |
| CN107058416B (en) | Fermentation process for refining glutamic acid | |
| CN104450806A (en) | Method for preparing sodium gluconate with enzymatic method | |
| KR20100100874A (en) | Method for producing succinic acid | |
| CN110564789B (en) | Method for producing L-theanine by using escherichia coli fermentation | |
| KR100857215B1 (en) | Method for producing high purity gamma aminobutyric acid using enzyme | |
| CN113072599A (en) | Method for preparing natural hesperidin by biological fermentation and extraction | |
| CN101104862B (en) | Synthesis of D-arylglycine by heterogeneous enzyme-catalyzed hydrolysis of 5-arylhydantoin | |
| CN107475320A (en) | The Green production method of L asparatates | |
| CN105316273A (en) | L-aspartase recombinant escherichia coli without malic acid byproduct and construction method and application thereof | |
| CN103923959B (en) | A kind of D Tagatose production methods based on enzymatic isomerization reaction and continuous chromatography separation coupling in situ | |
| CN117778281A (en) | Recombinant genetic engineering bacterium and preparation method of (R) -2- (1-aminoethyl) -4-fluorophenol | |
| CN117448309A (en) | Preparation method of immobilized hyacinase and its application in pregabalin intermediates | |
| CN101130798A (en) | Method for preparing sodium L-aspartate by bio-enzyme | |
| CN116926138A (en) | A process for producing acrylamide at a controlled rate based on microbial methods | |
| CN101575621A (en) | High concentration fermentation process of 2-keto-D-gluconic acid mixed salt | |
| AU2021102566A4 (en) | Co-production process of pyruvic acid and Levodopa and use thereof | |
| CN111235192B (en) | Process for producing, separating and purifying L-phenylalanine | |
| KR20080085377A (en) | Method for preparing L-ornithine salt | |
| CN113913478A (en) | A kind of method of fermenting Brevibacterium flavum to produce L-valine | |
| CN113025669A (en) | Preparation method of L-norvaline | |
| CN113355371A (en) | Method for preparing 4-hydroxyisoleucine through whole-cell catalysis | |
| CN118995652B (en) | Amine dehydrogenase, gene, recombinant bacteria, crude amine dehydrogenase enzyme solution, dehydrogenase composition, crude dehydrogenase enzyme solution composition and method for preparing (R)-3-aminobutanol | |
| CN107760726B (en) | Method for efficiently preparing mannonic acid by multi-microorganism step-by-step fermentation | |
| CN112813130B (en) | Production method of D-aspartic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210111 Address after: 570145 room 1506, Yusha international, 11-8 Yusha Road, Longhua District, Haikou City, Hainan Province Patentee after: Quanku (Hainan) Intellectual Property Operation Co.,Ltd. Address before: 050018 No. 70 East Yuhua Road, Hebei, Shijiazhuang Patentee before: HEBEI University OF SCIENCE AND TECHNOLOGY |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210415 Address after: 050018 No. 70 East Yuhua Road, Hebei, Shijiazhuang Patentee after: HEBEI University OF SCIENCE AND TECHNOLOGY Address before: 570145 room 1506, Yusha international, 11-8 Yusha Road, Longhua District, Haikou City, Hainan Province Patentee before: Quanku (Hainan) Intellectual Property Operation Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100519 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |